NewsRx

Search our medical news database

W. L. Gore & Associates, Inc.

Gore Receives Approval to Market GORE TAG Thoracic Endoprosthesis in Japan

Published in Cardiovascular Week, June 16th, 2008

W. L. Gore & Associates, Inc. (Gore) announced that it has received regulatory clearance from the Pharmaceuticals and Medical Device Agency (PMDA), to market the GORE TAG(R) Thoracic Endoprosthesis in Japan. The GORE TAG Device is used to treat aneurysms of the descending thoracic aorta, the largest artery in the body. The GORE TAG Device was designated as the highest priority device for expedited PMDA review by the various physician societies in Japan. The GORE TAG Device, the first approved thoracic stent-graft in the United States, was approved for use in the U.S. in March of 2005.

Patients with a thoracic aortic aneurysm are at risk of death due to internal bleeding...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cardiovascular Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook